Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP146 | DOI: 10.1530/endoabs.81.EP146

ECE2022 Eposter Presentations Calcium and Bone (114 abstracts)

Quality of life in chronic hypoparathyroidism on conventional treatment

Nikolay Gins 1 , Alina Elfimova 2 , Elena Kovaleva 2 , Anna Eremkina 2 & Natalia Mokrysheva 3

1Endocrinology Research Centre, Department of Epidemiology of Endocrinopathy, Moscow, Russian Federation; 2Endocrinology Research Centre, Department of Parathyroid Disorders, Moscow, Russian Federation; 3Endocrinology Research Centre, Director, Moscow, Russian Federation.

Introduction: Reduced health-related quality of life (HRQoL) is common in patients with hypoparathyroidism (HypoPT) treated conventionally with calcium and active vitamin D supplements.

Aim: we studied the HRQoL in patients with chronic HypoPT estimated with the 36-Item Short-Form Health Survey (SF-36) and multidimensional fatigue inventory (MFI-20).

Methods: 64 patients with chronic HypoPT (women/men – 57/7, median age 47[36;59] years) participated in the study. The median duration of the disease was 4 years [3;9]. SF-36 is a 36-item QOL questionnaire with response alternative scores 1–6 for each item. A scoring algorithm transforms the raw score to a score from 0 to 100, where a high score indicates better HRQoL. MFI-20 has an even proportion of positively and negatively worded items that are rated on a 5-point Likert scale. Subscale scores are calculated as the sum of item ratings and a total fatigue score – as the sum of subscale scores. Higher scores indicate a higher level of fatigue.

Results: we didn’t find any associations between the SF-36 and MFI-20 scores of and serum calcium levels. However, HypoPT patients with magnesium (Mg) level under 0,7 mmol/l had significantly higher SF-36 scores such as PF (P=0.0131); BP (P=0.0034); RE (P=0.0376); PH (P=0.0042). We found a negative correlation between the number of tablets and SF-36 PF score (P=0.0133; r=−0.31). Median of tablets’ number in patients with Mg<0.7 mmol/l is 6[5;10] vs median of tablets’ number 7[5;10] in patients with Mg≥0.7 mmol/l. But the difference isn’t significant. Duration of HypoPT had a positive correlation with SF-36 scores VT(P=0.0083; r=0.33), MH(P=0.2594; r=0.04) and negative correlations with some MFI-20 scores – general fatigue (P=0.015; r=−0.31), reduced activity (P=0.0336; r=−0.27) and reduced motivation (P=0.0088; r=−0.33). These results may be related to the phenomenon of adaptation to chronic diseases such as HypoPT. In general, the presence of HypoPT complications had a positive correlation with SF-36 scores VT(P=0.0496; r=0.25), SF(P=0.0013; r=0.39) and negative correlation with reduced activity (P=0.0204; r=−0.29). These results also can be explained by better examination and thus better awareness in patients with chronic HypoPT, especially if they already have at least one complication.

Conclusion: further studies with better instruments for assessing HRQoL are required. Patients with HypoPT often can use a lot of medications and should follow the strict rules of their taking, which can significantly affect the HRQoL. Of course, doctors want to improve all mineral disturbances, but therapy should be personalized and clearly discussed with the patients.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.